É, F., É, M., R, G., SE, W., NZ, J., C, Q., . . . N, B. (2026). Does an off-label two-dose RotaTeq vaccine schedule translate into a higher incidence of rotavirus hospital admissions compared to the approved three-dose RotaTeq schedule? A Canadian immunization research network study. Vaccine, 83, 128628. https://doi.org/10.1016/j.vaccine.2026.128628
Chicago Style (17th ed.) CitationÉ, Fortin, et al. "Does an Off-label Two-dose RotaTeq Vaccine Schedule Translate into a Higher Incidence of Rotavirus Hospital Admissions Compared to the Approved Three-dose RotaTeq Schedule? A Canadian Immunization Research Network Study." Vaccine 83 (2026): 128628. https://doi.org/10.1016/j.vaccine.2026.128628.
MLA (9th ed.) CitationÉ, Fortin, et al. "Does an Off-label Two-dose RotaTeq Vaccine Schedule Translate into a Higher Incidence of Rotavirus Hospital Admissions Compared to the Approved Three-dose RotaTeq Schedule? A Canadian Immunization Research Network Study." Vaccine, vol. 83, 2026, p. 128628, https://doi.org/10.1016/j.vaccine.2026.128628.